E
Elucida Oncology
Elucida Oncology is focused on transforming outcomes for patients with primary solid tumor and metastatic cancer
About Elucida Oncology
Elucida Oncology is a clinical-stage biotechnology company focused on developing advanced cancer therapies. The company operates in the oncology sector, targeting cancer treatment through its innovative ultra-small nanoparticle drug conjugate (CDC) platform. This technology is designed to penetrate deeper into tumors and deliver a significantly higher payload compared to traditional antibody drug conjugates (ADCs). Elucida Oncology's CDCs offer greater avidity for target antigens, longer retention in tumors, and minimal systemic exposure due to rapid renal clearance. The company's business model revolves around pioneering next-generation cancer treatments, aiming to bring these therapies to market through clinical trials and regulatory approvals. Revenue generation is anticipated through the commercialization of these therapies, either independently or through partnerships with larger pharmaceutical companies. Elucida Oncology serves patients with cancer, healthcare providers, and the broader medical community, operating primarily in the biotechnology and pharmaceutical markets.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jun 2023 | $23M | $220M | Undisclosed | ↗ |
| SERIES AOther financing | Jan 2021 | $44M | $176M | Undisclosed | — |
Growth signals
Latest recorded traffic for Elucida Oncology is 300 monthly website visits, down 3.2% over the last three months. Elucida Oncology's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Elucida Oncology in the New York City ecosystem
The Elucida Oncology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Elucida Oncology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Elucida Oncology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








